 MALVERN, Pa., June 09, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. NASDAQ: OCGN, a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, today announced that Michael Shine, Ocugens Senior Vice President, Commercial, will present at the 2022 BIO International Convention being held in San Diego, California, from June 13-16, 2022. 